Skip to main content
BML, INC. logo

BML, INC. — Investor Relations & Filings

Ticker · 4694 ISIN · JP3799700004 LEI · 5493003Y6Y1P8HBEL806 T Human health and social work activities
Open in API
Filings indexed 80 across all filing types
Latest filing 2026-03-16 Regulatory Filings
Country US United States of America
Listing T 4694

About BML, INC.

https://www.bml.co.jp/eng/

BML, Inc. is a provider of comprehensive laboratory testing services and medical information systems. The company's core business is contract clinical testing for medical institutions, offering a wide range of laboratory analyses. These services span from routine biochemical and hematological tests to specialized areas such as microbiological, genome-related, and tumor marker testing. In addition to its laboratory operations, BML develops and provides medical informatics solutions, including software for clinical testing. The company operates an extensive network of laboratories to process samples and report results to customers in the medical field.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of a semi-annual report (半期報告書) for the period ending September 30, 2025. Since this is a regulatory filing confirming the accuracy of a report rather than the report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the general regulatory filing category.
2026-03-16 Japanese
訂正半期報告書－第71期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a Japanese '半期報告書' (Semi-Annual Report) for BML, Inc., covering the interim period from April 1, 2025, to September 30, 2025. It contains detailed financial statements, including the balance sheet and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2026
2026-03-16 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. This specific document is a mandatory attachment to the Annual Securities Report (Yukashoken Hokokusho) where the CEO confirms the accuracy of the report's contents. Since it is a regulatory filing required by law that does not fit into the primary financial report categories (like 10-K or IR) and is not an announcement of a report, it falls under the general regulatory filings category. FY 2025
2026-03-16 Japanese
訂正有価証券報告書－第70期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). The header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act, covering the fiscal year from April 1, 2024, to March 31, 2025. It contains extensive XBRL tagging and financial data, confirming it is the full annual report rather than an announcement or summary. FY 2025
2026-03-16 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of a semi-annual report (Interim Report) for the period ending September 30, 2024. Since this is a regulatory filing confirming the validity of financial reporting and does not fit into the specific categories of the reports themselves (like 10-K or IR) or other specialized categories, it is classified as a Regulatory Filing (RNS).
2026-03-16 Japanese
訂正半期報告書－第70期(2024/04/01－2025/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a Japanese 'Semiannual Report' (半期報告書) for BML, Inc. for the period ending September 30, 2024. It contains detailed financial statements, including the balance sheet, and is filed under the Financial Instruments and Exchange Act. As it is a comprehensive financial report for a period shorter than a full fiscal year (interim period) and contains substantive financial data, it is classified as an Interim/Quarterly Report. H1 2025
2026-03-16 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.